← Leaderboards
Todd D Schell
Pennsylvania State Univ Hershey Med Ctr
$4,776,698
Attributed
$6,679,736
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $753.2K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,679,736 · 4
By mechanism
R01$5,621,970 · 2
S10$631,365 · 1
R21$426,401 · 1
Top collaborators
- Gavin P. Robertson6 shared
- Shantu G Amin4 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Kevin Finnbar Staveleyo'carroll$5,239,458
- Christopher Norbury$13,146,672
- Gavin P. Robertson$6,707,206
- W. Larry Kenney$10,723,575
- Alexandros N Vgontzas$3,874,274
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsMediatingTumorResponseImmune ResponseT-LymphocyteProteinsImmunotherapyBaseCd8-Positive T-LymphocytesMelanomaNeoplastic CellCharacteristicsPathway InteractionsImmuneLinkTumor ProgressionPharmacotherapyPositioning AttributeDesignCd8b1 GeneImmune FunctionAnimals
Grant awards (15)
The BD FACSDiscover S8 Cell Sorter for Flow Cytometric Sorting$631,365
S10 · FY2025 · OD · contact PI
Targeting Aldehyde Dehydrogenase for Cancer Prevention$558,440
R01 · FY2024 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention$587,645
R01 · FY2023 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention$600,507
R01 · FY2022 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention$628,206
R01 · FY2021 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention$125,000
R01 · FY2021 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention$641,281
R01 · FY2020 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors$363,051
R01 · FY2014 · CA · contact PI
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors$351,876
R01 · FY2013 · CA · contact PI
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors$374,388
R01 · FY2012 · CA · contact PI
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors$374,436
R01 · FY2011 · CA · contact PI
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors$386,069
R01 · FY2010 · CA · contact PI
Neuroendocrine Modulation of T Cell Immunity to Cancer$193,875
R21 · FY2010 · AI · contact PI
Neuroendocrine Modulation of T Cell Immunity to Cancer$232,526
R21 · FY2009 · AI · contact PI
Biology of SV40-Specific Transplantation Antigen$631,071
R01 · FY2007 · CA · contact PI